Pages that link to "Q38484762"

Jump to navigation Jump to search
What links here
⧼whatlinkshere-whatlinkshere-target⧽
⧼whatlinkshere-whatlinkshere-ns⧽
⧼whatlinkshere-whatlinkshere-filter⧽

The following pages link to Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02). (Q38484762):

Displaying 50 items.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)